109 related articles for article (PubMed ID: 10357247)
1. Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists.
Campbell KM; McGrath MJ; Burton FH
Eur J Pharmacol; 1999 Apr; 371(2-3):103-11. PubMed ID: 10357247
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion.
Campbell KM; McGrath MJ; Burton FH
Brain Res; 1999 Jul; 833(2):216-24. PubMed ID: 10375697
[TBL] [Abstract][Full Text] [Related]
3. OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons.
Campbell KM; de Lecea L; Severynse DM; Caron MG; McGrath MJ; Sparber SB; Sun LY; Burton FH
J Neurosci; 1999 Jun; 19(12):5044-53. PubMed ID: 10366637
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder.
McGrath MJ; Campbell KM; Parks CR; Burton FH
Brain Res; 2000 Sep; 877(1):23-30. PubMed ID: 10980239
[TBL] [Abstract][Full Text] [Related]
5. Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior.
McGrath MJ; Campbell KM; Veldman MB; Burton FH
Behav Pharmacol; 1999 Sep; 10(5):435-43. PubMed ID: 10780249
[TBL] [Abstract][Full Text] [Related]
6. The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior.
McGrath MJ; Campbell KM; Burton FH
Behav Neurosci; 1999 Dec; 113(6):1249-56. PubMed ID: 10636303
[TBL] [Abstract][Full Text] [Related]
7. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction.
Campbell KM; Veldman MB; McGrath MJ; Burton FH
Neuroreport; 2000 Jul; 11(10):2335-8. PubMed ID: 10923696
[TBL] [Abstract][Full Text] [Related]
8. "Hyperglutamatergic cortico-striato-thalamo-cortical circuit" breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome.
Nordstrom EJ; Bittner KC; McGrath MJ; Parks CR; Burton FH
Brain Res; 2015 Dec; 1629():38-53. PubMed ID: 26453289
[TBL] [Abstract][Full Text] [Related]
9. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
Gioanni Y; Thierry AM; Glowinski J; Tassin JP
Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons.
Watanabe K; Kimura M
J Neurophysiol; 1998 May; 79(5):2568-80. PubMed ID: 9582229
[TBL] [Abstract][Full Text] [Related]
11. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
Nordstrom EJ; Burton FH
Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
[TBL] [Abstract][Full Text] [Related]
12. Altered Functional Connectivity of the Orbital Cortex and Striatum Associated with Catalepsy Induced by Dopamine D1 and D2 Antagonists.
Niu M; Kasai A; Seiriki K; Hayashida M; Tanuma M; Yokoyama R; Hirato Y; Hashimoto H
Biol Pharm Bull; 2021; 44(3):442-447. PubMed ID: 33642553
[TBL] [Abstract][Full Text] [Related]
13. D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice.
Rinaldi A; Mandillo S; Oliverio A; Mele A
Neuropsychopharmacology; 2007 Feb; 32(2):309-19. PubMed ID: 16900106
[TBL] [Abstract][Full Text] [Related]
14. Habituation to test procedure modulates the involvement of dopamine D2- but not D1-receptors in ethanol-induced locomotor stimulation in mice.
Pastor R; Miquel M; Aragon CM
Psychopharmacology (Berl); 2005 Nov; 182(3):436-46. PubMed ID: 16133139
[TBL] [Abstract][Full Text] [Related]
15. Ethanol-induced sensitization depends preferentially on D1 rather than D2 dopamine receptors.
Camarini R; Marcourakis T; Teodorov E; Yonamine M; Calil HM
Pharmacol Biochem Behav; 2011 Apr; 98(2):173-80. PubMed ID: 21184775
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
17. The involvement of D1 and D2 dopamine receptors in amphetamine-induced changes in striatal unit activity in behaving rats.
Rosa-Kenig A; Puotz JK; Rebec GV
Brain Res; 1993 Aug; 619(1-2):347-51. PubMed ID: 8374790
[TBL] [Abstract][Full Text] [Related]
18. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
19. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra.
Hemsley KM; Crocker AD
Neuropsychopharmacology; 2001 Oct; 25(4):514-26. PubMed ID: 11557165
[TBL] [Abstract][Full Text] [Related]
20. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
